Literature DB >> 12623161

Physiology and pathophysiology of K(ATP) channels in the pancreas and cardiovascular system: a review.

Susumu Seino1.   

Abstract

K(ATP) channels are present in pancreatic and extrapancreatic tissues such as heart and smooth muscle, and display diverse molecular composition. They contain two different structural subunits: an inwardly rectifying potassium channel subunit (Kir6.x) and a sulfonylurea receptor (SURX). Recent studies on genetically engineered Kir6.2 knockout mice have provided a better understanding of the physiological and pathophysiological roles of Kir6.2-containing K(ATP) channels. Kir6.2/SUR1 has a pivotal role in pancreatic insulin secretion. Kir6.2/SUR2A mediates the effects of K(ATP) channels openers on cardiac excitability and contractility and contributes to ischemic preconditioning. However, controversy remains on the physiological properties of the K(ATP) channels in vascular smooth muscle cells. Kir6.1 knockout mice exhibit sudden cardiac death due to cardiac ischemia, indicating that Kir6.1 rather than Kir6.2 is critical in the regulation of vascular tone. This article summarizes current understanding of the physiology and pathophysiology of Kir6.1- and Kir6.2-containing K(ATP) channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623161     DOI: 10.1016/s1056-8727(02)00274-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  12 in total

Review 1.  Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.

Authors:  Michael J Riedel; Diana C Steckley; Peter E Light
Journal:  Hum Genet       Date:  2004-11-23       Impact factor: 4.132

2.  Endosomal KATP channels as a reservoir after myocardial ischemia: a role for SUR2 subunits.

Authors:  Li Bao; Krassimira Hadjiolova; William A Coetzee; Michael J Rindler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

3.  Kir6.2 limits Ca(2+) overload and mitochondrial oscillations of ventricular myocytes in response to metabolic stress.

Authors:  Nina M Storey; Rebecca C Stratton; Richard D Rainbow; Nicholas B Standen; David Lodwick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

4.  Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression.

Authors:  Tetiana V Serebrovska; Alla G Portnychenko; Tetiana I Drevytska; Vladimir I Portnichenko; Lei Xi; Egor Egorov; Anna V Gavalko; Svitlana Naskalova; Valentina Chizhova; Valeriy B Shatylo
Journal:  Exp Biol Med (Maywood)       Date:  2017-07-31

5.  The mitochondrial bioenergetic phenotype for protection from cardiac ischemia in SUR2 mutant mice.

Authors:  Nitin T Aggarwal; Danijel Pravdic; Elizabeth M McNally; Zeljko J Bosnjak; Nian-Qing Shi; Jonathan C Makielski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

6.  Glibenclamide depletes ATP in renal proximal tubular cells by interfering with mitochondrial metabolism.

Authors:  Richard Engbersen; Rosalinde Masereeuw; Miriam A van Gestel; Elise M J van der Logt; Paul Smits; Frans G M Russel
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 7.  SUR1-TRPM4 channels, not KATP, mediate brain swelling following cerebral ischemia.

Authors:  Seung Kyoon Woo; Natalia Tsymbalyuk; Orest Tsymbalyuk; Svetlana Ivanova; Volodymyr Gerzanich; J Marc Simard
Journal:  Neurosci Lett       Date:  2019-12-31       Impact factor: 3.046

Review 8.  BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema.

Authors:  Melissa Pergakis; Neeraj Badjatia; Seemant Chaturvedi; Carolyn A Cronin; W Taylor Kimberly; Kevin N Sheth; J Marc Simard
Journal:  Expert Opin Investig Drugs       Date:  2019-10-24       Impact factor: 6.206

Review 9.  Pharmacological treatment of hyperglycemia in type 2 diabetes.

Authors:  Simeon I Taylor; Zhinous Shahidzadeh Yazdi; Amber L Beitelshees
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

10.  Pharmacological polysulfide suppresses glucose-stimulated insulin secretion in an ATP-sensitive potassium channel-dependent manner.

Authors:  Tomohiro Shoji; Mikio Hayashi; Chisato Sumi; Munenori Kusunoki; Takeo Uba; Yoshiyuki Matsuo; Hideo Kimura; Kiichi Hirota
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.